1. Home
  2. MED vs ANIX Comparison

MED vs ANIX Comparison

Compare MED & ANIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MEDIFAST INC

MED

MEDIFAST INC

HOLD

Current Price

$11.45

Market Cap

122.8M

ML Signal

HOLD

Logo Anixa Biosciences Inc.

ANIX

Anixa Biosciences Inc.

HOLD

Current Price

$3.20

Market Cap

119.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MED
ANIX
Founded
1980
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Packaged Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
122.8M
119.8M
IPO Year
1996
2013

Fundamental Metrics

Financial Performance
Metric
MED
ANIX
Price
$11.45
$3.20
Analyst Decision
Hold
Strong Buy
Analyst Count
1
3
Target Price
$12.00
$8.67
AVG Volume (30 Days)
190.1K
229.4K
Earning Date
05-04-2026
05-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
12.82
EPS
N/A
N/A
Revenue
$934,842,000.00
$210,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.22
$2.32
52 Week High
$14.67
$5.46

Technical Indicators

Market Signals
Indicator
MED
ANIX
Relative Strength Index (RSI) 54.42 43.51
Support Level $9.90 $2.73
Resistance Level $12.21 $3.53
Average True Range (ATR) 0.57 0.17
MACD 0.11 -0.06
Stochastic Oscillator 51.91 12.96

Price Performance

Historical Comparison
MED
ANIX

About MED MEDIFAST INC

Medifast Inc is a old health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a simple, yet comprehensive approach to address obesity and support a healthy life. The company provides unparalleled coaching support along with community, tailored nutrition and healthy habits, and empowers people to master their weight loss journey through each stage of life. The company has access to GLP-1 medications where clinically appropriate. The company is focused on offering talent to Lifelong Transformation, Making a Healthy Lifestyle Second Nature.

About ANIX Anixa Biosciences Inc.

Anixa Biosciences Inc is a biotechnology company developing therapies and vaccines focused on critical unmet needs in oncology. Its operations are organized into reportable segments comprising Cancer Vaccines, CAR-T Therapies, and Other. The Cancer Vaccines segment involves vaccines to treat and prevent breast and ovarian cancer, as well as additional cancer vaccines targeting intractable cancers, including high-incidence malignancies in lung, colon, and prostate. The CAR-T Therapies segment involves the development of liraltagene autoleucel (lira-cel), an ovarian cancer immunotherapy using chimeric endocrine receptor-T cell technology, developed at its subsidiary, Certainty Therapeutics, Inc. The Other segment consists of legacy operations, including limited patent licensing activities.

Share on Social Networks: